Shaila Hussain

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Courses of treatment with a combination of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (NSC-45388) (850 mg/m2), cyclophosphamide (750 mg/m2), and vincristine (2.0 mg/m2) were given intravenously in single doses to patients with metastatic malignant melanoma. Treatment was repeated at 4-week intervals. Objective responses were observed in five of 20(More)
Glioblastoma multiforme (GBM) is a high-grade primary brain tumour with a notably poor prognosis. Research demonstrates a median survival of just over 1 year following aggressive treatment. Long-term survival is notably rare. Cranial radiotherapy and postexcisional prophylactic treatment is associated with the development of second, histologically distinct(More)
  • 1